CD68 Market Developments in Biomarker Detection and Tissue Profiling 2034
The CD68 Market is supported by increasing research into autoimmune and fibrotic diseases. Macrophage populations are involved in several inflammatory and tissue-remodeling processes, making their characterization valuable in experimental and translational studies. The CD68 Market was valued at US$ 804.62 million in 2025 and is expected to reach US$ 1,563.69 million by 2034, registering a CAGR...
0 Comments 0 Shares 13 Views 0 Reviews